BCAN applauds Representative Rooney for resolution to recognize National Bladder Cancer Awareness Day

The Bladder Cancer Advocacy Network (BCAN), the first national advocacy organization dedicated to improving public awareness of bladder cancer, applauds U.S. Representative Tom Rooney (R-Fla.) for introducing a resolution to recognize July 17, 2010 as "National Bladder Cancer Awareness Day."

The first annual Bladder Cancer Awareness Day will raise awareness of bladder cancer and its symptoms, so everyone will be able to recognize the signs and seek prompt medical attention. More than two dozen volunteer-led events will be held nationwide. Each event will also provide a forum for bladder cancer patients, survivors and their caregivers to meet and greet each other, share their stories and form lasting friendships.  

"Bladder cancer affects tens of thousands of American families, but it is highly treatable when diagnosed early," Rooney said.  "As with many types of cancer, early detection is critical to treating and recovering from the disease." 

"Bladder cancer is prevalent but is not discussed," said Diane Zipursky Quale, president and co-founder of BCAN. "In sponsoring the first annual Bladder Cancer Awareness Day, we hope to send the message to bladder cancer survivors and caregivers that they are not alone.  In fact, there are over 600,000 survivors living in this country."

Bladder cancer is the fifth most commonly diagnosed cancer in the United States. Approximately 70,000 new cases of bladder cancer are diagnosed annually and more than 14,000 Americans die from the disease each year. The most frequent symptom of the disease is blood in the urine – a signal that one should see one's doctor immediately.

SOURCE Bladder Cancer Advocacy Network

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Scientists map cancer mutations in EGFR gene, revealing drug resistance paths